arGEN-X Aktie

628,20EUR -20,20EUR -3,12%
arGEN-X für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A11602 / ISIN: NL0010832176

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 650 843 1 148 1 599 0
Umsatz pro Mitarbeiter in Mio. EUR 0,65 0,46 0,99 1,27 0,00

Bilanz (in Mio. EUR) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 2 236 2 599 3 733 4 716 5 874
Summe Anlagevermögen 270 337 379 1 274 1 519
Summe Aktiva 2 506 2 937 4 112 5 990 7 393

Bilanz (in Mio. EUR) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 278 300 403 680 1 158
Summe Eigenkapital 2 228 2 636 3 709 5 310 6 235
Summe Passiva 2 506 2 937 4 112 5 990 7 393

Adresse

Laarderhoogtweg 25, 1101 EB Amsterdam
Telefon +31 (76) 303-04-88
Internet http://www.argen-x.com

Management

Ana Cespedes
Independent Non-Executive Director
Anthony Adam Rosenberg
Independent Non-Executive Director
Arjen Lemmen
Vice President-Corporate Development & Strategy
Beth Delgiacco
VP-Corporate Communications & Investor Relations
Brian L. Kotzin
Non-Executive Director
Camilla Sylvest
Independent Non-Executive Director
Filip Borgions
Chief Technology Innovation Officer
Hemamalini Moorthy
General Counsel
James M. Daly
Independent Non-Executive Director
Joseph Donald deBethizy
Vice Chairman
Karen Massey
Chief Operating Officer
Karl Gubitz
Chief Financial Officer
Luc Truyen
Chief Medical Officer
Marc Schorpion
Global Head-Human Resources
Pamela M. Klein
Independent Non-Executive Director
Peter K. M. Verhaeghe
Non-Executive Chairman
Peter Ulrichts
Chief Scientific Officer
Sandrine Piret-Gérard
Chief Commercialization Officer
Steve E. Krognes
Independent Non-Executive Director
Tim van Hauwermeiren
Chief Executive Officer & Executive Director